❝ healthcare❞
Xellera Therapeutics is a focused CDMO providing GMP-compliant manufacturing services for Cell and Gene Therapy (CGT) and Advanced Therapy Products (ATP). The organization supports therapy developers across the entire lifecycle, including process development, clinical manufacturing, and commercial scale-up. Through advanced infrastructure, regulatory expertise, and robust quality systems, Xellera Therapeutics helps ensure product quality, accelerate timelines, and enable successful delivery of innovative therapies to patients.
New Territories
+852 2618 3356
For detailed company information including leadership contacts:
